Valuation : Almirall, S.A.

Market Cap 2.27B 2.64B 2.14B 1.95B 3.65B 249B 3.66B 25.23B 9.79B 128B 9.9B 9.69B 412B P/E 2026 *
26.9x
P/E 2027 * 19.2x
Enterprise Value 2.18B 2.53B 2.05B 1.87B 3.5B 239B 3.51B 24.19B 9.39B 123B 9.5B 9.29B 395B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.51x
Free-Float
35.93%
Yield 2026 *
1.95%
Yield 2027 * 2.02%
1 day+0.19%
1 week+0.97%
Current month+0.97%
1 month-4.93%
3 months-6.63%
6 months-14.45%
Current year-18.85%
1 week 10.22
Extreme 10.22
10.54
1 month 10.22
Extreme 10.22
11.06
Current year 10.22
Extreme 10.22
13.98
1 year 10.22
Extreme 10.22
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.83
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 02/11/2022
Director of Finance/CFO 53 31/08/2025
Chief Tech/Sci/R&D Officer - 07/07/2021
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member - 01/01/2016
Chairman - 06/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
6/23/23 A Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 A Buy 4,340 0.0024%
6/22/23 A Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+0.97%-6.29%+8.60% 2.64B
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -0.87%+1.08%+24.84%+46.88% 368.1B
Weighted average by Cap. -1.10%+0.55%+36.59%+66.18%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.16B 1.06B 1.97B 135B 1.98B 13.65B 5.3B 69.12B 5.36B 5.24B 223B 1.35B 1.57B 1.27B 1.16B 2.17B 148B 2.18B 15.03B 5.83B 76.1B 5.9B 5.77B 245B
Net income 82.4M 95.75M 77.52M 70.82M 132M 9.04B 133M 916M 355M 4.64B 360M 352M 14.94B 115M 134M 109M 99.17M 186M 12.66B 186M 1.28B 498M 6.5B 504M 493M 20.93B
Net Debt -93.03M -108M -87.53M -79.96M -150M -10.21B -150M -1.03B -401M -5.24B -406M -397M -16.87B -228M -265M -214M -196M -366M -25B -367M -2.53B -983M -12.83B -994M -973M -41.33B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
04/09/26 €10.42 +0.19% 89,852
03/09/26 €10.40 -0.57% 121,612
02/09/26 €10.46 -0.38% 139,426
01/09/26 €10.50 +1.74% 133,134
31/08/26 €10.32 0.00% 261,137
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.42EUR
Average target price
14.30EUR
Spread / Average Target
+37.24%

Quarterly revenue - Rate of surprise